All Stories

  1. Medicare vs. Medicare Advantage Plans: Essential Information for Healthcare Professionals Working with Older Adults
  2. Kidney Impairment and α-Synucleinopathy
  3. Delirium Guideline Recommendations
  4. Medicare Provider Pro's & Con's
  5. Why independent practice healthcare professionals can't unionize
  6. Consequences of U.S. COVID-19 Policy in 2024
  7. Auvelity as a Potential Treatment for Alzheimer’s Disease
  8. Ageism, Mentalism, and Ableism Shape Telehealth Policy
  9. U.S. COVID-19 Policy in 2023
  10. Assessing Delirium at Hospital Discharge
  11. Research Aspects in Biological Science Vol. 9
  12. Donepezil and α‐synuclein Constipation: A 60 Month Follow-Up
  13. Brief test to assess IT use
  14. Donepezil and \(\alpha\) -synuclein Constipation: A Longitudinal Study
  15. Update on the Functional Assessment of Currently Employed Technology Scale (FACETS) 4.0
  16. Reliability and Validity of the Functional Assessment of Currently Employed Technology Scale (FACETS)
  17. Telehealth Policy and Access to Care
  18. U.S. COVID-19 Policy: Politics Trump Science
  19. Auvelity as a Potential Treatment for Alzheimer’s Disease
  20. COVID-19, Telehealth and Access to Care
  21. Donepezil and α-synuclein Constipation: A 48 Month Follow-Up
  22. Telehealth Reimbursement Allows Access to Mental Health Care During COVID-19
  23. Functional Assessment Of Currently Employed Technology Scale (FACETS) 4.0: Update On A Brief Intake Instrument To Facilitate Treatment Planning And Communication With Patients
  24. Prevalence and Treatment of Constipation in Patients with Alpha-Synuclein Pathology
  25. Donepezil and α-synuclein Constipation: A 36 Month Follow-Up
  26. The internet: Barrier to health care for older adults?
  27. Donepezil for α‐synuclein Constipation: An 18 Month Follow-Up
  28. Donepezil for Constipation in Lewy Body Disease: A Twelve-Month Follow-Up
  29. Multidisciplinary care model for older adults
  30. Mechanisms of α‐Synuclein Pathology and Treatment in the Enteric Nervous System
  31. Donepezil for Constipation in Lewy Body Diseases: Four Case Studies
  32. Donepezil for Lewy Body Constipation: A Six-Month Follow-up
  33. Medications linked to cognitive impairment in older adults
  34. Neurocognitive disorder with Lewy bodies: Evidence-based diagnosis and treatment.
  35. The clinical pharmacology of paroxetine in healthy subjects
  36. An empirical assessment of bulimic patients using multiple measures
  37. Gender and Sex-Role Orientation Effects on Friendship Choice
  38. Evoked Potential Correlates of Genetic Progressive Hearing Loss: Age-related Changes from the Ear to the Inferior Colliculus of C57BL/6 and CBA/J Mice